An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
Gout patients have a high burden of co-morbid conditions including diabetes mellitus (DM), chronic kidney disease (CKD), and cardiovascular disease (CVD). We sought to evaluate the association between changes in serum uric acid (SUA) levels over time and the risk of incident DM, CVD, and renal funct...
Main Authors: | Rishi J Desai, Jessica M Franklin, Julia Spoendlin-Allen, Daniel H Solomon, Goodarz Danaei, Seoyoung C Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5831471?pdf=render |
Similar Items
-
Estimation of Serum Uric Acid in Cases of Hyperuriceamia and Gout
by: R K Pokharel, et al.
Published: (2011-03-01) -
Factors Influencing the Serum Uric Acid in Gout with Cerebral Infarction
by: Yi Li, et al.
Published: (2021-01-01) -
Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01) -
Gout, hyperuricemia and cardio-vascular risk
by: Laura Morbidoni, et al.
Published: (2018-06-01) -
Levels of serum uric acid and risk of myocardial infarction among gout patients
by: Abdussamad, Abdalla Ali
Published: (2016)